Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.49B | 34.59B | 26.49B | 18.68B | 15.12B | 14.27B |
Gross Profit | 18.84B | 24.35B | 18.84B | 13.48B | 11.12B | 10.46B |
EBITDA | 2.70B | 4.52B | 2.73B | 1.03B | 768.99M | 776.57M |
Net Income | 1.43B | 2.83B | 1.43B | 413.79M | 386.27M | 141.93M |
Balance Sheet | ||||||
Total Assets | 11.16B | 14.45B | 11.16B | 8.46B | 6.70B | 6.45B |
Cash, Cash Equivalents and Short-Term Investments | 2.77B | 3.96B | 2.77B | 2.13B | 1.53B | 1.39B |
Total Debt | 2.85B | 2.45B | 2.85B | 3.22B | 2.64B | 2.77B |
Total Liabilities | 7.30B | 7.78B | 7.30B | 6.00B | 4.47B | 4.53B |
Stockholders Equity | 3.87B | 6.67B | 3.87B | 2.46B | 2.23B | 1.91B |
Cash Flow | ||||||
Free Cash Flow | 1.16B | 1.67B | 1.16B | 134.37M | 385.85M | 363.89M |
Operating Cash Flow | 2.44B | 2.97B | 2.44B | 1.36B | 969.39M | 753.03M |
Investing Cash Flow | -1.37B | -1.32B | -1.37B | -1.29B | -630.21M | -366.96M |
Financing Cash Flow | -466.71M | -497.15M | -466.71M | 499.30M | -239.44M | 54.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥55.34B | 17.85 | 0.11% | 28.23% | 67.30% | ||
70 Outperform | ¥51.33B | 34.54 | 1.16% | 4.50% | -10.16% | ||
67 Neutral | ¥53.15B | 33.59 | 0.74% | 12.83% | 16.22% | ||
67 Neutral | ¥51.19B | 55.30 | 0.60% | 12.04% | -48.52% | ||
60 Neutral | ¥51.91B | 38.14 | 0.58% | 12.99% | 49.09% | ||
56 Neutral | HK$23.37B | 3.96 | -1.56% | 6.69% | 0.06% | -64.88% | |
56 Neutral | ¥50.68B | 18.73 | 2.25% | 9.82% | 159.81% |